PGRN 2026 Scientific Meeting in Collaboration with ClinPGx
Registration Rates
| Category | Early Bird Until July 27 | Advanced | On Site |
|---|---|---|---|
| PGRN Standard Member | $375 | $575 | $950 |
| PGRN Trainee and Developing Country Member | $100 | $150 | $350 |
| Non-Member | $600 | $800 | $1,200 |
| Non-PGRN CPIC Member | $500 | $700 | $1,100 |
ACPE® CE credit will be available for pharmacists. More information can be found here.
Accommodation & Venue Information
Accommodation Information
Hotel accommodation details, preferred rates, and travel information for the 2026 Scientific Meeting are available on our Plan Your Trip page.
Main Scientific Sessions
Thorne Auditorium, Arthur Rubloff Building
Northwestern University
Chicago Medical Campus
375 E Chicago Ave
Chicago, IL 60611
Chicago Medical Campus
375 E Chicago Ave
Chicago, IL 60611
Additional Programming
Simpson & Kimberly Querrey Biomedical Center
Poster Sessions, Lunch & Learn, and Breakout Sessions
303 E Superior St
Chicago, IL 60611
303 E Superior St
Chicago, IL 60611
Please note that the meeting will take place on Northwestern University's Chicago Medical Campus, not the undergraduate campus in Evanston, Illinois.
Preliminary Scientific Program The preliminary scientific program below provides an overview of the confirmed sessions and activities for the PGRN 2026 Annual Scientific Meeting in Collaboration with ClinPGx. Session topics, speakers, presentation titles, and timings remain subject to change as the program is finalized.
Friday, September 25 | Pre-Conference Day
The pre-conference program includes a morning session followed by two concurrent afternoon sessions. Participants should attend the pre-conference session for which they are registered. Morning Pre-Conference Session Applying Implementation Science Principles to Enhance the Adoption of Pharmacogenomics Time: 10:00 AM–12:30 PM
10:00–10:10 AM
Welcome
Sony Tuteja and Jennifer Young
10:10–10:25 AM
Introduction to Implementation Science
Deborah Duquette
10:25–10:45 AM
Theories, Models, and Frameworks
Jennifer Young
10:45–11:10 AM
Interactive Implementation Science Activity
Sony Tuteja and Jennifer Young
11:10–11:40 AM
Implementation Outcomes, Measures, and Study Design
Sony Tuteja
11:40 AM–12:00 PM
Implementation Strategies
Rachel Stone
12:00–12:25 PM
Interactive Implementation Science Activity
Sony Tuteja and Jennifer Young
12:25–12:30 PM
Wrap-Up
Sony Tuteja
12:30–1:00 PM | Lunch Break (Lunch Not Provided)
Concurrent Afternoon Pre-Conference Sessions
The All of Us Workshop and PGx 201 will take place concurrently. Participants should attend the session for which they are registered. All of Us Workshop Time: 1:00–5:15 PM
1:00–1:05 PM
Welcome
Minoli Perera
1:05–1:30 PM
The All of Us Research Program: New Data, Resources, and Research Opportunities
Jason Karnes
1:30–1:45 PM
Advancing Pharmacogenomics with All of Us: Emerging Data and Applications
Phil Empey
1:45–2:30 PM
Getting Started with Researcher Workbench 2.0: Accessing Clinical and Medication Data for Pharmacogenomics Research
Lin Suleiman
2:30–3:30 PM
Research in Action: Pharmacogenomics Studies Using All of Us Data — Lightning Research Presentations
Ola Al-Azzeh, Mona Alshahawey, and Lusi Zhang
3:30–3:45 PM
Break
3:45–4:30 PM
Hands-On Tutorial: Creating Research Workspaces and Building Cohorts in Researcher Workbench 2.0
Lin Suleiman
4:30–5:15 PM
Hands-On Tutorial: Conducting Pharmacogenomic Analyses Using Researcher Workbench 2.0
Anthony Vicenti PGx 201 Time: 1:00–4:45 PM 1:00–1:10 PM Welcome Kelly Caudle 1:10–1:30 PM
Implementing PGx Testing in Clinical Practice: Key Considerations Across the Testing Lifecycle
Yuan Ji Moderated by Sherin Shaaban 1:30–1:50 PM
You Are Not Alone: Practical Tools and Resources for PGx Implementation
Reynold Ly Moderated by Sherin Shaaban 1:50–2:10 PM
Lessons Learned from Implementing a PGx Program: Challenges, Solutions, and Clinical Impact
Debbie Figueroa Moderated by Sherin Shaaban 2:10–2:30 PM
Panel Discussion
2:30–3:00 PM
Break
3:00–4:30 PM
Managing Knowledge, CDS, and Change: The Evolving Role of Informatics in Clinical PGx
Amanda Massmann, Mark Dunnenberger, and Robert Freimuth 4:30–4:45 PM
USP Effort for Laboratory Standardization
Victoria Cancelliere Additional Activities
4:00–5:00 PM
Oncology Special Interest Group Meeting
5:00–6:00 PM
Clinical Practice Special Interest Group Meeting
6:00–8:00 PM
Welcome Social Reception
Olivia Caffe Beach Bar — Casual Attire Welcome
Saturday, September 26 | Scientific Meeting
8:00–9:00 AM
Concurrent activities
PGRN Breakfast Networking Session
Connect with representatives from PGRN committees, working groups, and special interest groups during this informal networking session.
ClinPGx User Meeting
9:00–9:30 AM
Welcome and Opening Remarks
Minoli Perera, PGRN President
9:30–10:30 AM
Keynote Session I
Moderated by Minoli Perera
VA National Pharmacogenomics Program
Deepak Voora — Duke University and U.S. Department of Veterans Affairs
10:30–10:45 AM | Break
10:45 AM–12:00 PM
Multi-omics Moderated by Steve Scherer
Bridging Patients, Cell Lines, and Drugs: Multi-Omics and Network Medicine Models for Predicting Cancer Drug Response
Barnabithi Bose — University of Colorado Anschutz Medical Campus
GRIN2 Enables Genome-Wide, Multi-Level Evidence Integration to Identify and Prioritize Clinically Relevant Pharmacogenomic Biomarkers
Abdelrahman Elsayed — St. Jude Children’s Research Hospital
Beyond Conventional GWAS: Leveraging Local Ancestry and Multi-Omics to Advance Precision Pharmacogenomics in Admixed Populations
Jorge Duconge — University of Puerto Rico
12:30–1:30 PM
Industry Microsessions
Illumina and Genomadix
12:00–1:30 PM | Lunch and Trainee/Early Career Meet & Greet
1:30–2:30 PM
Podium Presentations from Selected PGRN Abstracts Moderated by Jim Stevenson
Association of CYP2C19 and CYP2D6 Metabolizer Phenotypes with Serotonergic Antidepressant Outcomes in Common Mental Disorders
Santenna Chenchula — All India Institute of Medical Sciences (AIIMS), Bhopal, India
From Delay to Prediction: Integrating Machine Learning to Enable Proactive Pharmacogenetic-Guided Therapy
Sierra Scodellaro — Hospital for Sick Children, Toronto
Predicting the Functional Impact of Uncharacterized DPYD Missense Variants with MPACT-DPD: An Interpretable Machine Learning Classifier
Lulu Jiang — University of Iowa
Strong CYP2D6 Inhibitors Shift Solanidine Metabolic Ratios but Do Not Achieve PM-Level Phenoconversion in Youth
Brett Gilio — Children’s Mercy Kansas City
Genome-Wide Association of PF4/Heparin Antibodies in the All of Us Research Program
Andrew Klein — University of Arizona
2:30–2:45 PM | Break
2:45–3:45 PM
Substrate Specificity in Pharmacogenomics: Implications for CYP2D6 Phenotype Assignment and Clinical Implementation Moderated by Michelle Whirl-Carillo
Missing Heritability in Pharmacogenomics with Focus on Substrate Specificity Differences
Magnus Ingelman-Sundberg — Karolinska Institutet
Emerging Evidence for CYP2D6*17 Substrate Specificity: Lessons from Risperidone
Laura Ramsey — Children’s Mercy Kansas City
From Evidence to Action: Incorporating Substrate Specificity into CPIC Guidelines
Kelly Caudle — St. Jude Children’s Research Hospital
3:45–5:00 PM
AI in Pharmacogenomics: Transforming Research, Clinical Implementation, and Workforce Development
LLM-Enabled Drug Repurposing and Phenotyping: Lessons from an ADRD Case Study
Wei-Qi Wei — Vanderbilt University
From Guidelines to Practice: Leveraging AI to Scale Pharmacogenomic Clinical Decision Support and Education
Aniwaa Owusu Obeng — Icahn School of Medicine at Mount Sinai
Accelerating Pharmacogenomics Research Through Artificial Intelligence and Machine Learning
Max Weaver — Sanford Health, Sioux Falls
5:00–6:00 PM
Poster Session I
Sunday, September 27 | Scientific Meeting
8:00–8:50 AM
Poster Session II
9:00–10:00 AM
Keynote Session II
Moderated by Minoli Perera
The Genomic Basis of Doxorubicin-Induced Cardiotoxicity: eQTL Mapping Using Patient Specific hiPSC-Cardiomyocytes
Paul Burridge — Northwestern University Feinberg School of Medicine
10:00–10:15 AM | Break
10:15–11:45 AM
PGx Around the Globe Moderated by Nancy Hakooz
Analysis of Pharmacogenetic Practice in Chinese Hospitals: The Need for a Localized Evaluation Framework
Xiaoyian Nie — Peking University
From Pharmacogenomics to Pharmaco-Multi-Omics: Translating AI-Supported Precision Psychiatry into Clinical Practice
Kholud Bastaki Abdulla — Qatar University & Hamad Medical Corporation
Scaling Clinical Pharmacogenomics Through Denmark’s National Genomic Infrastructure
Peter Breining — University of Aarhus, Denmark
Bridging Pharmacokinetics and Pharmacogenetics in Drug Development: An Experience in Mexican Population
Carlos Diaz Tufinio — Tecnológico de Monterrey, School of Engineering and Sciences, Mexico City
11:45 AM–1:15 PM | Lunch Break
Grab-and-go lunch provided
1:15–2:15 PM
Newest Discoveries and Methods in PGx Moderated by Loren Saulsberry
Innovative Approaches to Advance Discovery for Pharmacogenequity in Renin Angiotensin Aldosterone System Inhibitor-Induced Angioedema
Akinyami Oni-Orisan — University of California, San Francisco
Multi-Trait Genetic Scores Elucidate Mechanisms of Cardio-Kidney Benefit and Predict Glycemic Response to GLP-1 Receptor Agonists
Leo Buckley — University of Texas Southwestern
Gene–Environment Interaction Studies in Pharmacogenomics: Lessons from PEGS and All of Us
Alison Motsinger-Rief — National Institute of Health
2:15–3:15 PM
To Act or Not to Act? Clinical Pharmacogenomics Practice Moderated by Andria Del Tredici
That MTHFR – How to Manage Expectations and Requests for Testing
Serena Mitaly — Ochsner Health
What to Do with F2 and F5
Kate Cummins — WellSpan Health
Beyond the Tumor: (Cautiously) Using Germline Pharmacogenetic Findings from Cancer Genomic Tests to Optimize Patient Care
Jai Patel — Advocate Health |
Support Our Travel Awards
If you would like to add a donation to support our travel awards, please fill out the form below.
For information or assistance please contact:
info@pgrn.org